Stock listing

Restart Life Sciences Corp.

Selected listing: HN30 · FWB · EUR · DE

Restart Life Sciences Corp. (Frankfurt:HN30), Health Technology. Latest release Oct 7, 2026: Restart Life Advances Licensed Intellectual Property Portfolio…

HN30:FWBEURDEUpdated September 26, 2026

Ticker: Frankfurt:HN30
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Other
Exchange: Frankfurt
Currency: EUR

About Restart Life Sciences Corp.

Restart Life Sciences Corp. (Ticker: HEAL) is a public company based in Canada, focusing on innovative solutions in the life sciences sector.

Latest news from Restart Life Sciences Corp.

Restart Life Advances Licensed Intellectual Property Portfolio Toward Commercial Launch

October 7, 2026

Restart Life Sciences Launches HC Protein+ Products Online and Advances AI-Driven E-Commerce Strategy

September 23, 2026

Holy Crap Foods to Exhibit at CHFA NOW Toronto, Debuting New Protein SKUs and Interactive AI Photo Experience

September 15, 2026

Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth

September 3, 2026

Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations

September 1, 2026

All Restart Life Sciences Corp. news →

Research Restart Life Sciences Corp.

Restart Life Sciences Corp. company profile

View the public company page for Restart Life Sciences Corp. on 6ix.

Restart Life Sciences Corp. news

Read company news and market updates connected to Restart Life Sciences Corp..

Restart Life Sciences Corp. investor events

Find investor webinars, events, and replay context for Restart Life Sciences Corp..